Assay systems for determination of fetal copy number variation
US11031095B2 · kind B2 · utility
0Cited by
121References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 21, 2012 |
| Grant date | Jun 8, 2021 |
| Priority date | — |
| Expiry date | Mar 10, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG16B20/20
- WIPO fieldComputer technology
- WIPO sectorElectrical engineering
Abstract
The present invention provides processes for determining accurate risk probabilities for chromosome dosage abnormalities. Specifically, the invention provides non-invasive evaluation of genomic variations through chromosome-selective sequencing and non-host fraction data analysis of maternal samples.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.